Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.777 USD | -2.23% | -31.86% | -44.51% |
Jun. 11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
Jun. 07 | Canaccord Genuity Adjusts Price Target on Seres Therapeutics to $10 From $15, Maintains Buy Rating | MT |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- MarketScreener Strategies